Teva Pharma (TEVA) Announces U.S. Launch of Generic INTUNIV Tabs
Tweet Send to a Friend
Teva Pharma (NYSE: TEVA) announced the launch of the generic equivalent to INTUNIV (guanfacine) 1 mg, 2 mg, 3 mg ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
